Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2018 | 2 |
2019 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Aberrant O-glycosylation modulates aggressiveness in neuroblastoma.
Oncotarget. 2018 Sep 25;9(75):34176-34188. doi: 10.18632/oncotarget.26169. eCollection 2018 Sep 25.
Oncotarget. 2018.
PMID: 30344930
Free PMC article.
Antibody-dependent cell-mediated cytotoxicity induced by active immunotherapy based on racotumomab in non-small cell lung cancer patients.
Segatori VI, Cuello HA, Gulino CA, Albertó M, Venier C, Guthmann MD, Demarco IA, Alonso DF, Gabri MR.
Segatori VI, et al. Among authors: cuello ha.
Cancer Immunol Immunother. 2018 Aug;67(8):1285-1296. doi: 10.1007/s00262-018-2188-y. Epub 2018 Jun 23.
Cancer Immunol Immunother. 2018.
PMID: 29936534
Free PMC article.
Item in Clipboard
Terminally sialylated and fucosylated complex N-glycans are involved in the malignant behavior of high-grade glioma.
Cuello HA, Ferreira GM, Gulino CA, Toledo AG, Segatori VI, Gabri MR.
Cuello HA, et al.
Oncotarget. 2020 Dec 29;11(52):4822-4835. doi: 10.18632/oncotarget.27850. eCollection 2020 Dec 29.
Oncotarget. 2020.
PMID: 33447350
Free PMC article.
Item in Clipboard
Expression of bladder cancer-associated glycans in murine tumor cell lines.
Albertó M, Cuello HA, Gulino CA, Pifano M, Belgorosky D, Gabri MR, Eiján AM, Segatori VI.
Albertó M, et al.
Oncol Lett. 2019 Mar;17(3):3141-3150. doi: 10.3892/ol.2019.9995. Epub 2019 Jan 31.
Oncol Lett. 2019.
PMID: 30867744
Free PMC article.
Item in Clipboard
Comparability of Antibody-Mediated Cell Killing Activity Between a Proposed Biosimilar RTXM83 and the Originator Rituximab.
Cuello HA, Segatori VI, Alberto M, Pesce A, Alonso DF, Gabri MR.
Cuello HA, et al.
BioDrugs. 2016 Jun;30(3):225-31. doi: 10.1007/s40259-016-0171-8.
BioDrugs. 2016.
PMID: 27053342
Item in Clipboard
Cite
Cite